Biotech Peptides
$44.00- Price / mg
- $8.80
- Document access
- Public link
Free USPS Priority over $200; lower-order rate not stated
Four public US 5 mg AOD-9604 research listings compared on one nominal vial size, with a lower price lacking a captured stock label retained below the available rows.
Current answer. As of Jul 23, 2026, 3 confirmed in-stock listings run from $44.00 to $50.00, with a $49.99 median across the in-stock rows. All 4 seller pages remain visible below.
Free USPS Priority over $200; lower-order rate not stated
Live UPS rate; free UPS 3 Day Select over $250
A list-price starting point, not a product-quality, safety, or seller recommendation.

List price, document access, and final landed cost answer different questions. This view keeps them separate instead of turning them into one seller score.
Free USPS Priority over $200; lower-order rate not stated
Open vendor evidence profile →COA, LC, and MS images. Access is public, but authenticity and custody are not established.
Inspect transparency record →This difference compares list prices only. It does not assign value to a report or include shipping.
Calculate landed cost →How to read it: The Biotech Peptides row is both the lowest confirmed in-stock list price and the lowest row with a public document route. Document visibility is not product verification.
Filter AOD-9604 vendors by stock, price, and public documents →Rank rule. Price rank is availability-aware and stays fixed when you search or re-sort this view. Affiliate status never enters the calculation.
Compare two lowest in-stock rowsChecked July 28, 2026 at 4:47 PM UTC. Confirmed means the public source matched the published price and returned a reliable current availability signal. No row needs manual review. This does not verify vial contents or product quality.
Open source-check ledger| Price rank / supplier | 5 mg price | Price / mg | Public evidence | Shipping claim | Open listing |
|---|---|---|---|---|---|
01Biotech PeptidesLowest confirmed in-stock list priceIn stock | $44.00Source confirmed | $8.80 | COA, LC, and MS imagesAccess: Public link · Seller claim · Jul 23, 2026 | Free USPS Priority over $200; lower-order rate not stated | |
02Purgo LabsCurrent public batch reportIn stock | $49.99Source confirmed | $10.00 | Public batch reportsAccess: Public link · Seller claim · Jul 23, 2026 | Live UPS rate; free UPS 3 Day Select over $250 | |
03Prime PeptidesPublic testing routeIn stock | $50.00Source confirmed | $10.00 | Report displayedAccess: Public link · Seller claim · Jul 23, 2026 | $9.95 US; free over $150 | |
04Core PeptidesLower price; stock label absentStatus not stated | $41.00Source confirmed | $8.20 | COA, HPLC, and MS tabsAccess: Public link · Seller claim · Jul 23, 2026 | Free over $200; lower-order rate at checkout |
1 In-stock headline prices exclude unavailable listings, coupons, and checkout-only discounts.
2 A seller COA or report is labeled as a claim unless Peptide Local commissioned the sample and controlled custody.
How we read a certificate of analysis →How to verify the seller and access route →Start with how the document can be reached, then match it to this exact AOD-9604 5 mg row. Access is useful evidence, but it does not prove authenticity, custody, vial contents, sterility, or suitability.
The exact 5 mg page exposed seller-hosted COA, liquid-chromatography, and mass-spectrometry images. Peptide Local did not verify the represented lot or chain of custody.
The exact 5 mg page was in stock and displayed a newly added public batch report dated July 16, 2026. Peptide Local did not authenticate custody or vial contents.
The seller page displayed a 5 mg option, ordering control, and public test-results route. Peptide Local recorded the route without verifying the represented material.
The exact 5 mg page showed a price, ordering control, and COA, HPLC, and mass-spectrometry tabs. A separate stock label was not captured, so it does not set the available low.
The free checker keeps compound identity, lot matching, dates, laboratory attribution, report verification, custody, purity, identity testing, instrument output, and quantity separate.
These canonical matchups open directly on the AOD-9604 5 mg board. Price, stock, document access, source freshness, and shipping stay separate.
Biotech Peptides is $6.00 lower before shipping.
Biotech Peptides is $5.99 lower before shipping.
Purgo Labs is $0.01 lower before shipping.
Biotech Peptides is the only row marked in stock.
Pair selection prioritizes rows that are currently comparable, include the board low, or expose a meaningful document-access contrast. It is not a seller ranking.
FDA lists AOD-9604 among bulk substances that may present significant safety risks in compounding, citing immunogenicity and peptide-impurity concerns plus limited human safety information.
Read the FDA source ↗Price, chemical identity, clinical evidence, approved-product status, and local supply are different questions. This map shows which source answers each one and leaves unresolved fields visible.
Evidence routes checked through Jul 23, 2026AOD-9604 reached controlled human studies, but the largest oral obesity trial did not show a statistically significant weight-loss difference and the sponsor terminated development for obesity. FDA states that neither AOD-9604 free base nor acetate is a component of an approved drug. Current seller-labelled 5 mg research vials do not inherit the identity, route, formulation, manufacturing record, or monitoring of the historical trial products.
Read the FDA sourceU.S. Food and Drug Administration↗The price board can compare current list price, nominal size, availability, shipping language, and seller document access. It cannot establish identity, quantity, purity, sterility, legality, or fitness for use.
Inspect every price and source row3 currently confirmed in stock↓AOD-9604 is outside Peptide Local's current 13-program trial-count snapshot. That means no local count is published here, not that the count is zero. Search the live registry, then inspect the intervention, status, population, and posted results for each record.
Search AOD-9604 on ClinicalTrials.govLive official registry route, not a cached result count↗The global index joins this identity to official product and seller or supply routes in 22 content languages. Only 3 countries currently have a separate compound-specific status finding in this dataset.
Open the complete worldwide mapIdentity, product, seller, and supply checks stay separate↗A country finding applies only to the cited identity, destination, source date, and stated scope. It does not authenticate a different product or seller.
FDA states that AOD-9604 free base and acetate are not components of an approved drug. The largest oral obesity study failed to show a statistically significant weight-loss difference, and the 2024 advisory committee voted 0 to 12 on placing the two forms on the 503A Bulks List. A public 5 mg research vial listing is not an approved product or the historical oral trial formulation.
Health Canada records a seller-labelled 5 mg AOD-9604 product among unauthorized injectable peptide products seized from a Canadian business. That finding does not authenticate or determine the status of a different listing, seller, presentation, or supply route.
SAHPRA names AOD-9604 among peptide products unlawfully marketed in South Africa and states that products intended to treat, prevent, or alter bodily functions must be registered before sale. That guidance does not authenticate a specific online listing or seller.
It can show the visible list price, normalized unit cost, availability label, delivery claim, document language, destination market, and date checked.
A seller page or uploaded certificate does not replace independent sampling, chain-of-custody evidence, regulatory authorization, or professional judgment.
Current exact-size answers for price, document access, shipping, and source checks. No seller is converted into a product-quality or safety recommendation.
As of Jul 23, 2026, the lowest confirmed in-stock public list price in Peptide Local's exact-size US research-market sample is $44.00 from Biotech Peptides. Shipping, tax, coupons, subscriptions, bundles, and checkout-only fees are not included.
3 confirmed in-stock rows link to a public seller document route: Biotech Peptides, Purgo Labs, Prime Peptides. The lowest of those rows is Biotech Peptides at $44.00. Public access does not authenticate a report, establish custody, or prove the contents of a supplied vial.
No. The board compares public single-unit list prices for the same 5 mg nominal size. The current lowest row states: Free USPS Priority over $200; lower-order rate not stated. Use the landed-cost calculator before treating the list-price order as the final order cost.
Confirm the exact identity and nominal size, current availability, landed cost, seller identity, destination-market rules, document route, lot or batch matching, analytical method, and source date. A seller-labelled research listing is not an approved medicine and public price or document access does not establish identity, purity, quantity, sterility, safety, legality, or fitness for human use.
Start by matching the exact AOD-9604 identity and 5 mg listing to a current lot or batch identifier. Then check analysis date, named laboratory, report verification route, sample custody, separate purity and identity methods, instrument output, and any measured quantity result. Peptide Local's free ten-field checker can organize those questions, but document completeness does not prove authenticity or the contents of a supplied vial.
These guides explain local verification and access routes. They do not relabel this US research-price board as local inventory or medical availability.